Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
A single-day inhaled mebufotenin regimen produced rapid, sustained symptom reductions through day 8 in 10 patients with postpartum depression, but the uncontrolled trial provides an early clinical signal rather than comparative efficacy evidence.
Clinical Pharmacology October 9th 2026
Clinical Advisor
Hospitals in multiple states have adopted postpartum notification wristbands intended to improve recognition of post-delivery complications. While proponents cite increased awareness and lower readmission rates at some institutions, evidence supporting broad outcome benefits remains limited.
Emergency Medicine August 31st 2026
MCN: The American Journal of Maternal/Child Nursing
A trauma-informed approach should guide the decision about oral misoprostol versus vaginal pharmacologic or mechanical methods because more vaginal exams may cause distress in some patients.
Maternal-Child Health Nursing February 26th 2026